Inhibrx Biosciences INBX
NASDAQ INBX
$96.99 -0.94 (-0.96%)
At close: Oct 2, 2026 · 4:00 PM EDT

Inhibrx Biosciences (INBX) Price to Sales (2024 - 2026)

Updated

Inhibrx Biosciences' (INBX) Price to Sales came in at 1072.05 for Q2 2026, up 678.5% from 137.71 a year earlier.

Analysis

Inhibrx Biosciences (INBX) Price to Sales (2024 - 2026) Analysis & Trends

For FY2025, Inhibrx Biosciences' Price to Sales stood at 885.87, down 20.5% from FY2024.

  • In prior years, Inhibrx Biosciences' Price to Sales was 1114.64 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Inhibrx Biosciences 1.43 Bn 1.43 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1,072.05
Dec 31, 2025 822.59
Sep 30, 2025 348.78
Jun 30, 2025 137.71
Dec 31, 2024 121.55
Sep 30, 2024 122.34
Jun 30, 2024 108.93
API Access

Inhibrx Biosciences Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=INBX&period=max&api_key=YOUR_API_KEY